Professional Resources
News and Events
Discover the latest news and events here.
Latest Press Releases
FDA Approves Cymbalta for the Management of Fibromyalgia
The U.S. Food and Drug Administration has approved Cymbalta (duloxetine HCl) to treat fibromyalgia, a chronic widespread pain disorder. Read more.
Events
Visit the Cymbalta promotional booth at the following medical congresses.
American Academy of Nurse Practitioners (AANP)
Baltimore, MD
Gaylord National on the Potomac
201 Waterfront St
Thursday-Monday, June 26-30, 2008
Register here
National Medical Association (NMA)
Atlanta, GA
Georgia World Congress Center
285 Andrew Young International Blvd
Saturday-Thursday, July 26-31, 2008
Learn more here
American Academy of Pain Management (AAPM)
Nashville, TN
Gaylord Opryland and Convention Center
2800 Opryland Dr
Monday-Thursday, September 8-11, 2008
Register here
American Academy of Family Physicians (AAFP)
San Diego, CA
San Diego Convention Center
111 W Harbor Dr
Wednesday-Sunday, September 17-21, 2008
Register here
American Osteopathic Association (AOA)
Las Vegas, NV
The Palazzo Hotel Resort Casino and Sands Convention Center
3325 Las Vegas Blvd. South
Sunday-Thursday, October 26-30, 2008
Register here
US Psychiatric and Mental Health Congress
San Diego, CA
San Diego Convention Center
111 W Harbor Dr
Thursday-Sunday, October 30-November 2, 2008
Register here
Cymbalta for Fibromyalgia
Cymbalta is indicated for the management of fibromyalgia.
Register to Receive Information From Cymbalta
Keep up-to-date on the latest developments with Cymbalta. Sign up now for our periodic emails.
Thought Leader Podcasts
Listen to peers and experts discuss the latest advances in diagnosis and treatment for MDD, GAD, DPNP, and fibromyalgia.
Listen to the podcasts now.
